386 related articles for article (PubMed ID: 29288126)
1. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
Davies JR; Rees J; Liu SM; Acharya KR
J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
[TBL] [Abstract][Full Text] [Related]
2. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
Pellett S; Bradshaw M; Tepp WH; Pier CL; Whitemarsh RCM; Chen C; Barbieri JT; Johnson EA
mBio; 2018 Mar; 9(2):. PubMed ID: 29588398
[TBL] [Abstract][Full Text] [Related]
3. Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
Henkel JS; Jacobson M; Tepp W; Pier C; Johnson EA; Barbieri JT
Biochemistry; 2009 Mar; 48(11):2522-8. PubMed ID: 19256469
[TBL] [Abstract][Full Text] [Related]
4. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
Kull S; Schulz KM; Weisemann J; Kirchner S; Schreiber T; Bollenbach A; Dabrowski PW; Nitsche A; Kalb SR; Dorner MB; Barr JR; Rummel A; Dorner BG
PLoS One; 2015; 10(2):e0116381. PubMed ID: 25658638
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the functional activity of botulinum neurotoxin subtype B6.
Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
[TBL] [Abstract][Full Text] [Related]
6. Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells.
Kohda T; Tsukamoto K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2020 Jul; 64(7):502-511. PubMed ID: 32301520
[TBL] [Abstract][Full Text] [Related]
7. High-resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6.
Davies JR; Britton A; Liu SM; Acharya KR
FEBS Open Bio; 2020 Aug; 10(8):1474-1481. PubMed ID: 32654405
[TBL] [Abstract][Full Text] [Related]
8. Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside.
Gregory KS; Mojanaga OO; Liu SM; Acharya KR
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202156
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.
Smith TJ; Hill KK; Foley BT; Detter JC; Munk AC; Bruce DC; Doggett NA; Smith LA; Marks JD; Xie G; Brettin TS
PLoS One; 2007 Dec; 2(12):e1271. PubMed ID: 18060065
[TBL] [Abstract][Full Text] [Related]
10. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
Kroken AR; Blum FC; Zuverink M; Barbieri JT
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795365
[TBL] [Abstract][Full Text] [Related]
11. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.
Davies JR; Liu SM; Acharya KR
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30347838
[TBL] [Abstract][Full Text] [Related]
12. Structural Features of
Gregory KS; Mahadeva TB; Liu SM; Acharya KR
Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622602
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3.
Leka O; Wu Y; Li X; Kammerer RA
J Biol Chem; 2021; 296():100684. PubMed ID: 33891946
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside.
Gregory KS; Liu SM; Acharya KR
FEBS Open Bio; 2020 Mar; 10(3):298-305. PubMed ID: 31945264
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR
Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023
[TBL] [Abstract][Full Text] [Related]
16. Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.
Bradshaw M; Tepp WH; Whitemarsh RC; Pellett S; Johnson EA
Appl Environ Microbiol; 2014 Dec; 80(23):7415-22. PubMed ID: 25239905
[TBL] [Abstract][Full Text] [Related]
17. Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM.
Košenina S; Martínez-Carranza M; Davies JR; Masuyer G; Stenmark P
Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050991
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of Clostridium botulinum serotype A strains by multiple-locus variable-number tandem-repeat analysis.
Macdonald TE; Helma CH; Ticknor LO; Jackson PJ; Okinaka RT; Smith LA; Smith TJ; Hill KK
Appl Environ Microbiol; 2008 Feb; 74(3):875-82. PubMed ID: 18083878
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
Shi DY; Lu JS; Mao YY; Liu FJ; Wang R; Du P; Yu S; Yu YZ; Yang ZX
Appl Microbiol Biotechnol; 2023 May; 107(10):3205-3216. PubMed ID: 37058230
[TBL] [Abstract][Full Text] [Related]
20. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
